CoChat

Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke

Open access

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Abstract

Stroke remains one of the most common causes of death and disability worldwide. Several preclinical studies demonstrated that the brain can be effectively protected against ischaemic stroke by two seemingly distinct treatments: remote ischaemic conditioning (RIC), involving cycles of ischaemia/reperfusion applied to a peripheral organ or tissue, or by systemic administration of glucagon-like-peptide-1 (GLP-1) receptor (GLP-1R) agonists. The mechanisms underlying RIC- and GLP-1-induced neuroprotection are not completely understood. In this study, we tested the hypothesis that GLP-1 mediates neuroprotection induced by RIC and investigated the effect of GLP-1R activation on cerebral blood vessels, as a potential mechanism of GLP-1-induced protection against ischaemic stroke. A rat model of ischaemic stroke (90 min of middle cerebral artery occlusion followed by 24-h reperfusion) was used. RIC was induced by 4 cycles of 5 min left hind limb ischaemia interleaved with 5-min reperfusion periods. RIC markedly (by ~ 80%) reduced the cerebral infarct size and improved the neurological score. The neuroprotection established by RIC was abolished by systemic blockade of GLP-1R with a specific antagonist Exendin(9–39). In the cerebral cortex of GLP-1R reporter mice, ~ 70% of cortical arterioles displayed GLP-1R expression. In acute brain slices of the rat cerebral cortex, activation of GLP-1R with an agonist Exendin-4 had a strong dilatory effect on cortical arterioles and effectively reversed arteriolar constrictions induced by metabolite lactate or oxygen and glucose deprivation, as an ex vivo model of ischaemic stroke. In anaesthetised rats, Exendin-4 induced lasting increases in brain tissue PO 2, indicative of increased cerebral blood flow. These results demonstrate that neuroprotection against ischaemic stroke established by remote ischaemic conditioning is mediated by a mechanism involving GLP-1R signalling. Potent dilatory effect of GLP-1R activation on cortical arterioles suggests that the neuroprotection in this model is mediated via modulation of cerebral blood flow and improved brain perfusion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00395-021-00873-9

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 GLP-1 receptors mediate neuroprotection against ischaemic stroke established by remote ischaemic conditioning. a Illustration of the experimental protocols. In rats, ischaemic stroke was induced by 90 min of middle cerebral artery occlusion (MCAO) followed by 24 h of reperfusion. Remote ischaemic conditioning (RIC) was established following 4 cycles of 5-min left hind limb ischaemia interleaved by 5-min reperfusion periods. Arrows indicate the time (20 min before the onset of reperfusion and/or 10 min prior to the application of the first RIC cycle) of intravenous administration of GLP-1 receptor antagonist Exendin(9–39) (Ex9). b Representative images of TTC-stained coronal brain sections from four experimental groups 24 h after MCAO. c, d Summary data illustrating the effect of RIC on brain infarct size and behavioural neurological traits 24 h after MCAO. Neuroprotection induced by RIC was prevented by systemic GLP-1 receptor blockade with Ex9. Infarct size is presented as a percentage of the hemispheric lesion volume (HLV). MCAO group, n = 7; MCAO + RIC group, n = 8; MCAO + Ex9 group, n = 7; and MCAO + Ex9/RIC group, n = 8 rats. Individual data and means ± SEM are shown. p values—ANOVA followed by Sidak’s correction for multiple comparisons
Fig. 1 GLP-1 receptors mediate neuroprotection against ischaemic stroke established by remote ischaemic conditioning. a Illustration of the experimental protocols. In rats, ischaemic stroke was induced by 90 min of middle cerebral artery occlusion (MCAO) followed by 24 h of reperfusion. Remote ischaemic conditioning (RIC) was established following 4 cycles of 5-min left hind limb ischaemia interleaved by 5-min reperfusion periods. Arrows indicate the time (20 min before the onset of reperfusion and/or 10 min prior to the application of the first RIC cycle) of intravenous administration of GLP-1 receptor antagonist Exendin(9–39) (Ex9). b Representative images of TTC-stained coronal brain sections from four experimental groups 24 h after MCAO. c, d Summary data illustrating the effect of RIC on brain infarct size and behavioural neurological traits 24 h after MCAO. Neuroprotection induced by RIC was prevented by systemic GLP-1 receptor blockade with Ex9. Infarct size is presented as a percentage of the hemispheric lesion volume (HLV). MCAO group, n = 7; MCAO + RIC group, n = 8; MCAO + Ex9 group, n = 7; and MCAO + Ex9/RIC group, n = 8 rats. Individual data and means ± SEM are shown. p values—ANOVA followed by Sidak’s correction for multiple comparisonsCC BY · PubMed Central
Fig. 2 GLP-1 receptor expression in cortical blood vessels. Representative images of coronal sections of the cerebral cortex of glp1r-Cre/ROSA26-tdRFP mouse, immunostained for red fluorescent protein (red), illustrating GLP-1 receptor expression associated with penetrating cortical arteriole (a), parenchymal arteriole (b), capillary (c), and venule (d). Arteriole smooth muscle cells were labelled by immunohistochemical detection of smooth muscle actin (SMA, green). Endothelial cells were labelled with lectin (blue). Arrows point to other cortical GLP-1 receptor-positive cells. Scale bars = 20 µm
Fig. 2 GLP-1 receptor expression in cortical blood vessels. Representative images of coronal sections of the cerebral cortex of glp1r-Cre/ROSA26-tdRFP mouse, immunostained for red fluorescent protein (red), illustrating GLP-1 receptor expression associated with penetrating cortical arteriole (a), parenchymal arteriole (b), capillary (c), and venule (d). Arteriole smooth muscle cells were labelled by immunohistochemical detection of smooth muscle actin (SMA, green). Endothelial cells were labelled with lectin (blue). Arrows point to other cortical GLP-1 receptor-positive cells. Scale bars = 20 µmCC BY · PubMed Central
Fig. 3 GLP-1 receptor activation dilates cortical arterioles. a Representative DIC images illustrating a cortical arteriole response to 5 mM lactate and GLP-1 receptor agonist Exendin-4 (Ex4; 100 nM), applied in the presence of lactate, recorded in a coronal slice of a rat cerebral cortex. The yellow dashed line outlines the edge of the vessel; the length of the white dotted line illustrates the smallest diameter of the vessel recorded during the course of the experiment. Scale bar = 10 µm. b Summary data illustrating changes in the diameter of cortical arterioles recorded over time and peak arteriolar responses induced by lactate applied in concentrations of 5 or 20 mM. c Summary data illustrating the effect of Ex4 on the diameter of cortical arterioles pre-constricted with lactate (5 mM). Lactate-evoked arteriolar constrictions were effectively reversed by Ex4. d Summary data illustrating the effect of Ex4 on the diameter of cortical arterioles pre-constricted with lactate (5 mM) in the presence of nitric oxide synthase inhibitor l-NAME (100 µM). l-NAME had no effect on Ex4-induced arteriolar dilations. e, Summary data illustrating the effect of Ex4 on the diameter of cortical arterioles pre-constricted with lactate (5 mM) in the presence of adenylate cyclase inhibitor SQ22536 (100 µM). SQ22536 prevented the arteriolar dilations induced by Ex4. Numbers in parentheses indicate the numbers of slices obtained from the same number of animals (biological replicates). Individual data and/or means ± SEM are shown. p values—paired t test
Fig. 3 GLP-1 receptor activation dilates cortical arterioles. a Representative DIC images illustrating a cortical arteriole response to 5 mM lactate and GLP-1 receptor agonist Exendin-4 (Ex4; 100 nM), applied in the presence of lactate, recorded in a coronal slice of a rat cerebral cortex. The yellow dashed line outlines the edge of the vessel; the length of the white dotted line illustrates the smallest diameter of the vessel recorded during the course of the experiment. Scale bar = 10 µm. b Summary data illustrating changes in the diameter of cortical arterioles recorded over time and peak arteriolar responses induced by lactate applied in concentrations of 5 or 20 mM. c Summary data illustrating the effect of Ex4 on the diameter of cortical arterioles pre-constricted with lactate (5 mM). Lactate-evoked arteriolar constrictions were effectively reversed by Ex4. d Summary data illustrating the effect of Ex4 on the diameter of cortical arterioles pre-constricted with lactate (5 mM) in the presence of nitric oxide synthase inhibitor l-NAME (100 µM). l-NAME had no effect on Ex4-induced arteriolar dilations. e, Summary data illustrating the effect of Ex4 on the diameter of cortical arterioles pre-constricted with lactate (5 mM) in the presence of adenylate cyclase inhibitor SQ22536 (100 µM). SQ22536 prevented the arteriolar dilations induced by Ex4. Numbers in parentheses indicate the numbers of slices obtained from the same number of animals (biological replicates). Individual data and/or means ± SEM are shown. p values—paired t testCC BY · PubMed Central
Fig. 4 GLP-1 receptor activation dilates cortical arterioles in the ex vivo model of ischaemic stroke. a Representative DIC images illustrating a cortical arteriole response to oxygen and glucose deprivation (OGD) followed by GLP-1 receptor agonist Exendin-4 (Ex4; 100 nM) applied in conditions of OGD, recorded in a coronal slice of a rat cerebral cortex. Scale bar = 10 µm. b Summary data illustrating changes in the diameter of cortical arterioles recorded over time and peak arteriolar responses induced by OGD. c Summary data illustrating the effect of Ex4 on the diameter of cortical arterioles in conditions of OGD in the absence and presence of GLP-1 receptor antagonist Ex9 (1 µM). Arteriolar constrictions induced by OGD were reversed by Ex4. d Summary data illustrating peak changes in the diameter of cortical capillaries induced by OGD and after application of Ex4 in conditions of OGD. Numbers in parentheses indicate the numbers of slices obtained from the same number of animals (biological replicates). Individual data and/or means ± SEM are shown. p values—paired (b, c) or unpaired (d) t test
Fig. 4 GLP-1 receptor activation dilates cortical arterioles in the ex vivo model of ischaemic stroke. a Representative DIC images illustrating a cortical arteriole response to oxygen and glucose deprivation (OGD) followed by GLP-1 receptor agonist Exendin-4 (Ex4; 100 nM) applied in conditions of OGD, recorded in a coronal slice of a rat cerebral cortex. Scale bar = 10 µm. b Summary data illustrating changes in the diameter of cortical arterioles recorded over time and peak arteriolar responses induced by OGD. c Summary data illustrating the effect of Ex4 on the diameter of cortical arterioles in conditions of OGD in the absence and presence of GLP-1 receptor antagonist Ex9 (1 µM). Arteriolar constrictions induced by OGD were reversed by Ex4. d Summary data illustrating peak changes in the diameter of cortical capillaries induced by OGD and after application of Ex4 in conditions of OGD. Numbers in parentheses indicate the numbers of slices obtained from the same number of animals (biological replicates). Individual data and/or means ± SEM are shown. p values—paired (b, c) or unpaired (d) t testCC BY · PubMed Central
Fig. 5 GLP-1 receptor activation increases cerebral blood flow in vivo. a Representative raw traces of changes in brain tissue partial pressure of oxygen (PtO2), heart rate (HR) and mean arterial blood pressure (MAP) after intravenous infusion of saline (0.1 ml) followed by GLP-1 receptor agonist Exendin-4 (Ex4; 10 μg kg−1, 0.1 ml volume) in an anaesthetised and artificially ventilated rat. Cx cerebral cortex. b Summary data illustrating changes in brain PtO2 recorded continuously for 30 min after the intravenous infusion of saline or Ex4 (10 μg kg−1) in anaesthetised and artificially ventilated rats (n = 6). c Summary data illustrating the lasting effect of GLP-1R activation on brain PtO2 in a separate cohort of animals (n = 5). 5 min-long recordings of PtO2 were taken at baseline and then 1,2, and 3 h after the administration of Ex4 (10 μg kg−1)
Fig. 5 GLP-1 receptor activation increases cerebral blood flow in vivo. a Representative raw traces of changes in brain tissue partial pressure of oxygen (PtO2), heart rate (HR) and mean arterial blood pressure (MAP) after intravenous infusion of saline (0.1 ml) followed by GLP-1 receptor agonist Exendin-4 (Ex4; 10 μg kg−1, 0.1 ml volume) in an anaesthetised and artificially ventilated rat. Cx cerebral cortex. b Summary data illustrating changes in brain PtO2 recorded continuously for 30 min after the intravenous infusion of saline or Ex4 (10 μg kg−1) in anaesthetised and artificially ventilated rats (n = 6). c Summary data illustrating the lasting effect of GLP-1R activation on brain PtO2 in a separate cohort of animals (n = 5). 5 min-long recordings of PtO2 were taken at baseline and then 1,2, and 3 h after the administration of Ex4 (10 μg kg−1)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Cited by

See all 77

Metadata

Authors
Nizari, S., Basalay, M., Chapman, P., Korte, N., Korsak, A., Christie, I. N., Theparambil, S. M., Davidson, S. M., Reimann, F., Trapp, S., Yellon, D. M., & Gourine, A. V.
Affiliations
  • University College London (GB)
  • University of Cambridge (GB)
Corresponding author
Gourine, Alexander V.
Venue
Basic Research in Cardiology
Published
2021-05-03
Volume
116
Issue
1
Pages
32-32
ISSN
  • 0003-9217 (ISSN-L)
  • 0300-8428
  • 1435-1803
OpenAlex
W3159867433
Cited by
77
References
91
Citations by year
2026: 11 · 2025: 21 · 2024: 15 · 2023: 9 · 2022: 20 · 2021: 1
FWCI
7.49
Type
journal article
Language
en
Open access
Licence
Locations
  • Basic Research in Cardiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Lancaster EPrints (Lancaster University) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Apollo
  • Apollo (cc-by)
Funders
Wellcome Trust (200893)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords
GLP-1 receptor, remote ischemic conditioning, ischemic stroke, neuroprotection, cerebral blood flow, cerebral arterioles, vasodilation, exendin-4, exendin-9-39, middle cerebral artery occlusion, oxygen-glucose deprivation, cerebral oxygenation, GLP-1 receptor agonists
MeSH terms
Glucagon-Like Peptide-1 Receptor, Ischemic Stroke, Animals, Arterioles, Cerebrovascular Circulation, Disease Models, Animal, Hindlimb, Male, Peptide Fragments, Regional Blood Flow, Vasodilation, Vasodilator Agents, Rats, Sprague-Dawley, Neuroprotective Agents, Ischemic Preconditioning, Infarction, Middle Cerebral Artery, Rats, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke. https://app.cochat.ai/papers/10.1007/s00395-021-00873-9
The paper
Nizari, S., Basalay, M., Chapman, P., Korte, N., Korsak, A., Christie, I. N., Theparambil, S. M., Davidson, S. M., Reimann, F., Trapp, S., Yellon, D. M., & Gourine, A. V. (2021). Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke. Basic Research in Cardiology. https://doi.org/10.1007/s00395-021-00873-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.